ROSEN, A LEADING LAW FIRM, Encourages Decision Diagnostics Corp. Investors with Losses In Excess of $100K to Secure Counsel Before Important Deadline – DECN The Rosen Law Firm PA New York, New York, UNITED STATES
NEW YORK, Feb. 14, 2021 (GLOBE NEWSWIRE)
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Decision Diagnostics Corp. (OTC: DECN) between March 3, 2020 and December 17, 2020, inclusive (the “Class Period”), of the important
March 16, 2021 lead plaintiff deadline.
SO WHAT: If you purchased Decision Diagnostics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Decision Diagnostics Class Action Reminder
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options
NEW YORK, NY / ACCESSWIRE / February 11, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff .
NEW YORK, NY / ACCESSWIRE / February 10, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.